Neurology and Huntington’s disease
Medibiofarma S.L. is active in clinical research for Huntington’s disease, with interest in treatments aimed at addressing neurological symptoms and disease-related functional decline.
- Neurodegenerative disease
- Movement disorder
- Symptom management
The sponsor’s neurology portfolio reflects a focus on therapeutic options for patients living with inherited neurodegeneration.
Gastroenterology and Crohn’s disease
Its clinical research also includes Crohn’s disease, with attention to inflammatory bowel disease and complications linked to intestinal narrowing and tissue remodeling.
- Inflammatory bowel disease
- Intestinal stenosis
- Fibrotic complications
These studies place gastrointestinal inflammation and fibrosis among the sponsor’s key therapeutic interests.
Women’s health and primary dysmenorrhea
Medibiofarma S.L. is also involved in research on primary dysmenorrhea, supporting clinical interest in pain conditions affecting women’s reproductive health.
- Menstrual pain
- Gynecological disorders
- Women’s reproductive health
This area highlights a therapeutic focus on managing pain-related gynecological conditions.
